Treatment of Male Urethritis
For male urethritis, first-line treatment is azithromycin 1g orally in a single dose or doxycycline 100mg orally twice daily for 7 days. 1
Diagnosis
Before initiating treatment, confirm urethritis with at least one of the following:
- Mucopurulent or purulent urethral discharge 1
- Positive leukocyte esterase test on first-void urine 1
- ≥10 WBC per high-power field on microscopic examination of first-void urine sediment 1
All patients with confirmed or suspected urethritis should be tested for:
Treatment Algorithm
First-line Treatment Options
OR
Alternative Regimens (if first-line options cannot be used)
- Erythromycin base 500mg orally four times a day for 7 days 1
- Erythromycin ethylsuccinate 800mg orally four times a day for 7 days 1
- Levofloxacin 500mg orally once daily for 7 days 1
- Ofloxacin 300mg orally twice a day for 7 days 1
Special Considerations
Empiric Treatment
- Empiric treatment without documentation of urethritis is recommended only for patients at high risk for infection who are unlikely to return for follow-up 1
- In such cases, treat for both gonorrhea and chlamydia 1
Partner Management
- All sex partners within the preceding 60 days should be referred for evaluation and treatment 1
- Partners should receive treatment effective against chlamydia regardless of whether a specific etiology is identified in the index patient 1
- Expedited partner treatment is an alternative approach 1
Post-Treatment Instructions
- Abstain from sexual intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen 1
- Sexual abstinence should continue until symptoms have resolved 1
- Sexual partners should be treated before resuming sexual activity 1
Management of Persistent or Recurrent Urethritis
If symptoms persist or recur after treatment:
- Confirm objective signs of urethritis before initiating further antimicrobial therapy 1, 3
- Rule out non-compliance with initial treatment or re-exposure to untreated partner 1, 3
- If compliant with initial regimen and re-exposure excluded, recommended treatment is:
Common Pitfalls to Avoid
- Treating based on symptoms alone without confirming objective signs of urethritis 1, 3
- Failing to test for both gonorrhea and chlamydia 1
- Not addressing possible reinfection from untreated partners 1, 3
- Overlooking the possibility of tetracycline-resistant Ureaplasma urealyticum or Mycoplasma genitalium in persistent cases 1
- Ignoring the need for follow-up if symptoms persist 1
Follow-Up
- Patients should return for evaluation if symptoms persist or recur after treatment 1
- Persistence of pain, discomfort, and irritative voiding symptoms beyond 3 months should prompt evaluation for chronic prostatitis/chronic pelvic pain syndrome 1
- Test-of-cure is not recommended for asymptomatic patients who received recommended treatment 1
- Consider repeat testing 3-6 months after treatment due to high rate of reinfection 1